Press release
Key Trend Reshaping the Idiopathic Pulmonary Fibrosis Market in 2025: Product Innovations Expanding Access And Affordability For Patients In The Idiopathic Pulmonary Fibrosis Market
Idiopathic Pulmonary Fibrosis Market
The growth of the idiopathic pulmonary fibrosis market is projected to be fuelled by an increase in the incidence of fibrotic disease. Fibrotic diseases, also known as fibrosis, are a collection of medical conditions that are characterized by an overabundance and accumulation of fibrous connective tissue in various organs or body tissues. Drugs for idiopathic pulmonary fibrosis are designed to decrease lung fibrosis and inflammation by acting on multiple signaling pathways associated with fibrosis. As per the American Lung Association, a U.S.-based lung association, in December 2022, there were roughly 207,000 individuals affected by this disease in the United States and around 58,000 new idiopathic pulmonary fibrosis cases diagnosed every year. This condition is found to be more prevalent in men than women, primarily affecting individuals aged over 50. As such, the escalation in the incidence of fibrotic disease is propelling the idiopathic pulmonary fibrosis market.
Get Your Idiopathic Pulmonary Fibrosis Market Report Here:
https://www.thebusinessresearchcompany.com/report/idiopathic-pulmonary-fibrosis-global-market-report
What is the projected compound annual growth rate (CAGR) of the idiopathic pulmonary fibrosis market from 2025 to 2034, and what factors influence it?
Recent years have seen a substantial growth in the market of idiopathic pulmonary fibrosis. The market, which is projected to expand from $4.15 billion in 2024 to $4.39 billion in 2025, has a compound annual growth rate (CAGR) of 5.6%. Factors such as an increasing elderly population, lack of ample treatment methods, heightened awareness of the disease, and improvement in healthcare infrastructure can be credited for the growth observed in the historic period.
The market size of idiopathic pulmonary fibrosis is predicted to experience robust expansion in the coming years. It is forecasted to reach a value of $5.74 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.0%. This projected growth within the forecast period can be credited to enhanced research and development, the introduction of precision medicine, rising incidence of the disease, progress in biomarker development, and government support and funding. Noteworthy trends expected during the forecast period encompass progress in diagnostic methodologies, the advent of targeted treatments, the use of telemedicine and remote oversight, combination treatments, and advances in lung transplantation procedures.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12579&type=smp
How are the latest trends influencing the growth of the idiopathic pulmonary fibrosis market?
The trend of product innovation is gaining traction in the idiopathic pulmonary fibrosis market as major corporations emphasize novel product developments to solidify their standing and gain a competitive edge. For example, in May 2022, Sandoz, the Swiss-based manufacturer of generic and biosimilar drugs, unveiled an AB-rated equivalent to Genentech's Esbriet, pirfenidone's generic version. This launch was targeted at the treatment of individuals with idiopathic pulmonary fibrosis (IPF). This prescribable oral medication is now available via specialty pharmacies, offering eligible patients the perk of a USD 0 co-pay program.
What are the major segments of the idiopathic pulmonary fibrosis market and their role in driving growth?
The idiopathic pulmonary fibrosis market covered in this report is segmented -
1) By Drug Type: Nintedanib, Pirfenidone, Other Drug Types
2) By Mode Of Action: Antifibrotic Agents, Tyrosine Kinase Inhibitors, Other Modes Of Action
3) By Route Of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Providers
5) By End Users: Hospitals And Clinics, Other End Users
Subsegments:
1) By Nintedanib: Indications, Dosage Forms, Administration Routes
2) By Pirfenidone: Indications, Dosage Forms, Administration Routes
3) By Other Drug Types: Specific Agents Or Classes, Emerging Therapies, Combination Therapies
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12579
Which regions are key players in the growth of the idiopathic pulmonary fibrosis market?
North America was the largest region in the idiopathic pulmonary fibrosis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the idiopathic pulmonary fibrosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the key firms paving the way for growth in the idiopathic pulmonary fibrosis market?
Major companies operating in the idiopathic pulmonary fibrosis market include F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., Gilead Sciences Inc., Toray Industries Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Sun Pharmaceutical Industries Limited, Shionogi and Co. Ltd., Cipla Inc., Zydus Lifesciences Ltd., Chong Kun Dang Pharmaceutical Corp., Kyorin Pharmaceutical Co. Ltd., Galapagos NV, Veracyte Inc., Genentech Inc., FibroGen Inc., GNI Group Ltd., Pliant Therapeutics Inc., Pulmatrix Inc., Galimedix Therapeutics Inc., Avalyn Pharma Inc., MediciNova Inc., Liminal BioSciences Inc., Beijing Continent Pharmaceuticals Company, Galecto Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12579&type=smp
What Is Covered In The Idiopathic Pulmonary Fibrosis Global Market Report?
• Market Size Forecast: Examine the idiopathic pulmonary fibrosis market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the idiopathic pulmonary fibrosis market for a structured understanding.
• Key Players Overview: Analyze major players in the idiopathic pulmonary fibrosis market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the idiopathic pulmonary fibrosis market.
• Segment Contributions: Evaluate how different segments drive overall growth in the idiopathic pulmonary fibrosis market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the idiopathic pulmonary fibrosis market.
• Industry Challenges: Identify potential risks and obstacles affecting the idiopathic pulmonary fibrosis market.
• Competitive Landscape: Review strategic developments in the idiopathic pulmonary fibrosis market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Trend Reshaping the Idiopathic Pulmonary Fibrosis Market in 2025: Product Innovations Expanding Access And Affordability For Patients In The Idiopathic Pulmonary Fibrosis Market here
News-ID: 3915529 • Views: …
More Releases from The Business Research Company
In-Depth Analysis of the Wind Market: Growth Opportunities, Key Trends, and Fore …
What Market Sizedynamics are playing a key role in accelerating the growth of the wind market?
The wind market's expansion is predicted to be driven by a burgeoning demand for renewable energy sources. These renewable power sources, which are replenished naturally over the human timescale without diminishing, are becoming more popular due to environmental considerations, political regulations, and climate objectives. Wind power plays a crucial role in renewable energy plans, offering…
A Deep Dive into Vitamin D Testing Market Size2025: Key Drivers, Growth Factors, …
Which drivers are expected to have the greatest impact on the over the vitamin d testing market's growth?
An increase in awareness about disorders originating from vitamin D deficiency is predicted to fuel the expansion of the vitamin D testing market. A vitamin D deficiency disorder is a health condition that arises when there is not enough vitamin D in the body, influencing calcium absorption adversely and causing problems like fragile…
Rising Neurodegenerative Disorders Fuel Growth In Vinpocetine Market SizeDriver: …
What industry-specific factors are fueling the growth of the vinpocetine market?
The upward trend in neurodegenerative condition cases is anticipated to boost the vinpocetine market's expansion. Neurodegenerative conditions involve a multitude of illnesses marked by the slow decay or death of nerve cells, known as neurons, in the brain or spinal cord. Numerous elements, including the growing elderly populace, unhealthy lifestyle choices, genetic predispositions, and environmental influences contribute to the escalating…
Impact of Rising Pet Ownership On The Growth Of The Veterinary Clinical Trials M …
What combination of drivers is leading to accelerated growth in the veterinary clinical trials market?
The veterinary clinical trials Market Sizeis poised for growth, driven by the increasing population of pet owners. Possessing and caring for one or more pets, referred to as pet ownership, is on the rise due to various reasons. These include the need for company, the therapeutic effects of pets, and enhanced understanding of their positive influence…
More Releases for Pharma
Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors.
Access the PDF sample of the report@…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period.
For More Info, Get Sample Report…
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide…
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry.
Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986
Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications…
